Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Beyond the Scale: Psychological and Behavioural Considerations Following GLP-1 Receptor Agonist Treatment Discontinuation

Diabetes, obesity & metabolism · 2026 Nov 3 · Newman AK, Billings LK et

MH
By Maren Holt · Senior Reporter, GLP-1
Nov 2 19:00 ETSource: Diabetes, obesity & metabolism

From the source

Beyond the Scale: Psychological and Behavioural Considerations Following GLP-1 Receptor Agonist Treatment Discontinuation

Diabetes, obesity & metabolism · 2026 Nov 3 · Newman AK, Billings LK et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →